CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.01−0.38 (-0.79%)
Close on Nov 18, 2026Market cap $1.43BP/E 19.8Yield 1.25%
Conmed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Conmed's operating income for the twelve months ending Sep 30, 2026 was $135.59M, up 14.4% year over year. For fiscal 2025 it was $102.62M, down 48.8% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $200.33M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.62M | -48.8% |
| FY2024 | Dec 31, 2024 | $200.33M | +66.1% |
| FY2023 | Dec 31, 2023 | $120.60M | +72.2% |
| FY2022 | Dec 31, 2022 | $70.05M | -36.2% |
| FY2021 | Dec 31, 2021 | $109.72M | +138.5% |
| FY2020 | Dec 31, 2020 | $46.01M | -41.8% |
| FY2019 | Dec 31, 2019 | $79.11M | +11.0% |
| FY2018 | Dec 31, 2018 | $71.31M | +51.9% |
| FY2017 | Dec 31, 2017 | $46.94M | +24.6% |
| FY2016 | Dec 31, 2016 | $37.68M | -26.4% |
| FY2015 | Dec 31, 2015 | $51.18M | -3.1% |
| FY2014 | Dec 31, 2014 | $52.79M | -6.6% |
| FY2013 | Dec 31, 2013 | $56.51M | -13.3% |
| FY2012 | Dec 31, 2012 | $65.21M | +688.1% |
| FY2011 | Dec 31, 2011 | $8.27M | -85.5% |
| FY2010 | Dec 31, 2010 | $57.09M | +102.0% |
| FY2009 | Dec 31, 2009 | $28.27M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $37.14M | +212.7% |
| Q2 FY2026 | Jun 30, 2026 | $36.41M | -4.6% |
| Q1 FY2026 | Mar 31, 2026 | $25.42M | +59.3% |
| Q4 FY2025 | Dec 31, 2025 | $36.62M | -30.2% |
| Q3 FY2025 | Sep 30, 2025 | $11.88M | -81.9% |
| Q2 FY2025 | Jun 30, 2025 | $38.16M | -19.0% |
| Q1 FY2025 | Mar 31, 2025 | $15.96M | -54.4% |
| Q4 FY2024 | Dec 31, 2024 | $52.50M | +4.6% |
| Q3 FY2024 | Sep 30, 2024 | $65.71M | +116.9% |
| Q2 FY2024 | Jun 30, 2024 | $47.11M | +71.8% |
| Q1 FY2024 | Mar 31, 2024 | $35.01M | +175.7% |
| Q4 FY2023 | Dec 31, 2023 | $50.19M | – |
| Q3 FY2023 | Sep 30, 2023 | $30.30M | +25.0% |
| Q2 FY2023 | Jun 30, 2023 | $27.42M | +12.1% |
| Q1 FY2023 | Mar 31, 2023 | $12.70M | -43.4% |
| Q4 FY2022 | Dec 31, 2022 | -$1.10M | -102.9% |
| Q3 FY2022 | Sep 30, 2022 | $24.25M | -9.2% |
| Q2 FY2022 | Jun 30, 2022 | $24.46M | -4.9% |
| Q1 FY2022 | Mar 31, 2022 | $22.44M | +11.8% |
| Q4 FY2021 | Dec 31, 2021 | $37.22M | +50.7% |
| Q3 FY2021 | Sep 30, 2021 | $26.71M | -9.1% |
| Q2 FY2021 | Jun 30, 2021 | $25.71M | – |
| Q1 FY2021 | Mar 31, 2021 | $20.08M | +52.5% |
| Q4 FY2020 | Dec 31, 2020 | $24.70M | -11.4% |
| Q3 FY2020 | Sep 30, 2020 | $29.38M | +40.3% |
| Q2 FY2020 | Jun 30, 2020 | -$21.25M | -213.9% |
| Q1 FY2020 | Mar 31, 2020 | $13.17M | +13.2% |
| Q4 FY2019 | Dec 31, 2019 | $27.88M | +8.0% |
| Q3 FY2019 | Sep 30, 2019 | $20.94M | +81.7% |
| Q2 FY2019 | Jun 30, 2019 | $18.66M | +11.8% |
| Q1 FY2019 | Mar 31, 2019 | $11.64M | -32.6% |
| Q4 FY2018 | Dec 31, 2018 | $25.82M | +11.4% |
| Q3 FY2018 | Sep 30, 2018 | $11.52M | -14.5% |
| Q2 FY2018 | Jun 30, 2018 | $16.68M | +30.5% |
| Q1 FY2018 | Mar 31, 2018 | $17.28M | – |
| Q4 FY2017 | Dec 31, 2017 | $23.18M | +83.8% |
| Q3 FY2017 | Sep 30, 2017 | $13.47M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.78M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.49M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.61M | – |
See a number that looks wrong?